ADHD medication use following FDA risk warnings.
Barry CL, Martin A, Busch SH. ADHD medication use following FDA risk warnings. The Journal Of Mental Health Policy And Economics 2012, 15: 119-25. PMID: 23001280, PMCID: PMC3896970.Peer-Reviewed Original ResearchConceptsMedical Expenditure Panel SurveyADHD medication usePost-marketing surveillance systemMedication useTreatment patternsAttention deficit/hyperactivity disorder (ADHD) medication useFDA safety warnings